These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 25987446)

  • 1. Academic-industrial partnerships in drug discovery in the age of genomics.
    Harris T; Papadopoulos S; Goldstein DB
    Trends Biotechnol; 2015 Jun; 33(6):320-2. PubMed ID: 25987446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Academia and industry: allocating credit for discovery and development of new therapies.
    Flier JS
    J Clin Invest; 2019 May; 129(6):2172-2174. PubMed ID: 31107243
    [No Abstract]   [Full Text] [Related]  

  • 3. Overcoming the obstacles in the pharma/biotech industry: 2008 update.
    Graul AI; Revel L; Rosa E; Cruces E
    Drug News Perspect; 2009; 22(1):39-51. PubMed ID: 19209298
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An analysis of original research contributions toward FDA-approved drugs.
    Patridge EV; Gareiss PC; Kinch MS; Hoyer DW
    Drug Discov Today; 2015 Oct; 20(10):1182-7. PubMed ID: 26113307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug discovery for the developing world: progress at the Novartis Institute for Tropical Diseases.
    Jones CL; Yeung BK; Manjunatha U; Shi PY; Bodenreider C; Diagana TT
    Nat Rev Drug Discov; 2015 Jun; 14(6):442-4. PubMed ID: 26027536
    [No Abstract]   [Full Text] [Related]  

  • 6. Modern phenotypic drug discovery is a viable, neoclassic pharma strategy.
    Lee JA; Uhlik MT; Moxham CM; Tomandl D; Sall DJ
    J Med Chem; 2012 May; 55(10):4527-38. PubMed ID: 22409666
    [No Abstract]   [Full Text] [Related]  

  • 7. Genomics and transcriptomics in drug discovery.
    Dopazo J
    Drug Discov Today; 2014 Feb; 19(2):126-32. PubMed ID: 23773860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. San Diego.
    Howard K
    Nature; 2003 Dec; 426(6967):689. PubMed ID: 14668871
    [No Abstract]   [Full Text] [Related]  

  • 9. Genomics and new technologies as catalysts for change in the drug discovery paradigm.
    Hanke J
    J Law Med Ethics; 2000; 28(4 Suppl):15-22. PubMed ID: 11244839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Consideration on Industry-Academia Partnering in Drug Discovery Development: Based on a Questionnaire Survey of Pharmaceutical Companies and Academia].
    Iida K; Yano T; Ikemori M; Ishida T; Nishimura N
    Yakugaku Zasshi; 2021 Jun; 141(6):877-886. PubMed ID: 33642438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rediscovering the sweet spot in drug discovery.
    Brown D; Superti-Furga G
    Drug Discov Today; 2003 Dec; 8(23):1067-77. PubMed ID: 14693466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. (Some) current concepts in antibacterial drug discovery.
    van Geelen L; Meier D; Rehberg N; Kalscheuer R
    Appl Microbiol Biotechnol; 2018 Apr; 102(7):2949-2963. PubMed ID: 29455386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Collaborative pre-competitive preclinical drug discovery with academics and pharma/biotech partners at Sanford|Burnham: infrastructure, capabilities & operational models.
    Chung TD
    Comb Chem High Throughput Screen; 2014 Mar; 17(3):272-89. PubMed ID: 24409951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The changing roles of industry and academia.
    Bauer EA; Cohen DE
    J Invest Dermatol; 2012 Mar; 132(3 Pt 2):1033-6. PubMed ID: 22330271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stategic trends in the drug industry.
    Drews J
    Drug Discov Today; 2003 May; 8(9):411-20. PubMed ID: 12706659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrating genomics across drug discovery and development.
    Debouck C
    Toxicol Lett; 2009 Apr; 186(1):9-12. PubMed ID: 18930125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 2011 in reflection.
    Mullard A
    Nat Rev Drug Discov; 2012 Jan; 11(1):6-8. PubMed ID: 22212664
    [No Abstract]   [Full Text] [Related]  

  • 19. How to develop therapeutic and translational research collaborations with industry.
    Kleiman RJ; Ehlers MD
    Mol Biol Cell; 2019 Oct; 30(22):2741-2743. PubMed ID: 31609671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Developing novel chemical entities for the treatment of lysosomal storage disorders: an academic perspective.
    Shayman JA
    Am J Physiol Renal Physiol; 2015 Dec; 309(12):F996-9. PubMed ID: 26447223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.